rps8 Antibody

What is RPS8 and what is its role in cellular function?

RPS8 is a ribosomal protein that functions as a component of the 40S subunit in ribosomes, the cellular organelles responsible for protein synthesis. The protein belongs to the S8E family of ribosomal proteins and is primarily located in the cytoplasm. Ribosomes consist of a small 40S subunit and a large 60S subunit, which together contain 4 RNA species and approximately 80 structurally distinct proteins . RPS8 is specifically encoded by a gene that produces a 208 amino acid protein with a calculated molecular weight of 24 kDa, though it is typically observed at 25-28 kDa in experimental conditions .

The gene encoding RPS8 has several interesting features that highlight its biological importance. It is co-transcribed with multiple small nucleolar RNA genes, specifically U38A, U38B, U39, and U40, which are located in its fourth, fifth, first, and second introns, respectively . This arrangement suggests potential regulatory relationships between RPS8 and these small nucleolar RNAs. Additionally, like many ribosomal proteins, RPS8 has multiple processed pseudogenes dispersed throughout the genome, which can complicate genetic analysis in certain experimental contexts .

Recent research has identified potential roles for RPS8 beyond its canonical function in protein synthesis. Notably, increased expression of RPS8 has been observed in colorectal tumors and colon polyps compared to matched normal colonic mucosa, suggesting potential involvement in cancer development or progression .

What applications are RPS8 antibodies suitable for?

RPS8 antibodies are versatile reagents applicable to multiple experimental techniques in molecular and cellular biology research. Based on validated applications, these antibodies are primarily suitable for Western Blot (WB), Immunofluorescence (IF)/Immunocytochemistry (ICC), Immunohistochemistry (IHC), and Enzyme-Linked Immunosorbent Assay (ELISA) .

Western Blot represents one of the most common applications, allowing researchers to detect and quantify RPS8 protein levels in cell or tissue lysates. The technique provides information about protein expression and can confirm the specificity of the antibody by demonstrating detection at the expected molecular weight (25-28 kDa for RPS8) .

Immunofluorescence and immunocytochemistry applications enable visualization of RPS8 distribution within cells, providing insights into its subcellular localization. For instance, positive IF/ICC detection has been validated in A375 cells . These techniques are valuable for studying potential translocation or redistribution of RPS8 under different experimental conditions.

Immunohistochemistry extends this visualization capability to tissue sections, allowing researchers to examine RPS8 expression patterns across different cell types within a tissue context. This application has been particularly useful in cancer research, such as studies investigating RPS8 as a potential biomarker in hepatocellular carcinoma .

ELISA applications provide a quantitative method for measuring RPS8 protein levels in solution, which can be useful for high-throughput screening or when analyzing samples not suitable for Western blot analysis .

What are the recommended protocols for Western blot using RPS8 antibody?

For optimal Western blot results with RPS8 antibody, researchers should adhere to established protocols with specific optimizations for this target. The recommended dilution range for Western blot applications is 1:500-1:2000, though the optimal dilution should be determined for each experimental system . This titration is essential because different cell types and tissue samples may require different antibody concentrations for optimal signal-to-noise ratio.

A typical Western blot protocol for RPS8 detection begins with sample preparation, where cells or tissues are lysed in an appropriate buffer containing protease inhibitors to prevent protein degradation. Since RPS8 has a relatively low molecular weight (24-28 kDa), a higher percentage (12-15%) SDS-PAGE gel is recommended for optimal resolution. After electrophoresis, proteins should be transferred to a nitrocellulose or PVDF membrane using standard transfer conditions.

For blocking, 5% non-fat dry milk or BSA in TBST (Tris-buffered saline with 0.1% Tween-20) is typically effective. The membrane should then be incubated with the primary RPS8 antibody diluted in blocking buffer overnight at 4°C. After washing with TBST, the membrane is incubated with an appropriate HRP-conjugated secondary antibody (typically anti-rabbit IgG for the polyclonal antibodies described in the search results) for 1-2 hours at room temperature .

Following additional washing steps, the signal can be detected using enhanced chemiluminescence (ECL) reagents. When interpreting results, researchers should expect to observe RPS8 at approximately 25-28 kDa, though the exact molecular weight may vary slightly depending on the specific cell type or experimental conditions .

What species reactivity can I expect from commercial RPS8 antibodies?

Commercial RPS8 antibodies demonstrate consistent reactivity across several mammalian species, with primary validated reactivity in human, mouse, and rat samples . This cross-reactivity stems from the high degree of conservation in RPS8 protein sequence across mammalian species. For example, the polyclonal antibody 18228-1-AP from Proteintech has been validated to show reactivity with human, mouse, and rat samples in Western blot applications, with positive detection confirmed in several cell lines including HeLa cells, SGC-7901 cells, PC-3 cells, and A375 cells, as well as in mouse liver and pancreas tissues .

The broad species reactivity of these antibodies makes them valuable tools for comparative studies across different model organisms. When working with species not explicitly validated by the manufacturer, preliminary experiments to confirm antibody specificity are strongly recommended. Western blot analysis showing a band at the expected molecular weight (approximately 24-28 kDa) would provide initial confirmation of reactivity in a new species .

How can RPS8 be used as a biomarker in cancer research?

Recent investigations have identified RPS8 as a promising biomarker candidate in certain cancer types, with notable significance in alcohol-associated hepatocellular carcinoma (HCC). Research utilizing techniques such as weight gene co-expression network analysis has revealed that RPS8 is highly expressed in alcohol-associated HCC tissues compared to adjacent non-tumor tissues, while showing no significant differential expression in non-alcohol-associated HCC . This specificity suggests potential utility as a diagnostic biomarker that could distinguish between different etiologies of HCC.

Gene Set Enrichment Analysis (GSEA) has demonstrated that samples with high RPS8 expression in alcohol-associated HCC show enrichment in ten pathways, including RNA polymerase and ribosome pathways . This association suggests that RPS8 may not merely be a passive marker but could potentially play a functional role in the disease progression, possibly through aberrant regulation of translation or other ribosome-related functions.

For researchers investigating RPS8 as a cancer biomarker, immunohistochemical analysis represents a practical approach. A validated protocol includes fixing tissue samples in 4% paraformaldehyde for 24 hours at room temperature, followed by dehydration using ethyl alcohol (98%) at 40°C and embedding in paraffin. After sectioning to 4-μm thickness, samples should be deparaffinized using xylene and rehydrated through a descending alcohol series. Antigen retrieval with sodium citrate at 100°C, blocking of endogenous peroxidase activity with 3% hydrogen peroxide, and blocking with 5% BSA for 30 minutes at room temperature are recommended preprocessing steps .

For immunostaining, incubation with primary anti-RPS8 antibody at a 1:40 dilution (for the 18228-1-AP antibody) for 12 hours at 4°C, followed by incubation with HRP-conjugated secondary antibody at 1:100 dilution for 2 hours at room temperature has proven effective . Signal development using DAB allows visualization, and quantification can be performed based on percentage scores of positive cells, with scores assigned as follows: 0 (0-1%), 1 (1-33%), 2 (34-66%), and 3 (67-100%) .

What are the optimal immunofluorescence protocols for RPS8 detection?

For researchers utilizing immunofluorescence to study RPS8 localization and expression, optimized protocols significantly enhance detection sensitivity and specificity. The recommended dilution range for immunofluorescence applications is 1:20-1:200, though this should be adjusted based on the specific cell type and fixation method employed . A375 cells have been validated for positive immunofluorescence detection of RPS8, making them a suitable positive control for protocol optimization .

A typical immunofluorescence protocol begins with cell culture on appropriate coverslips or chamber slides. Cells should be fixed with 4% paraformaldehyde in PBS for 15-20 minutes at room temperature, followed by permeabilization with 0.1-0.5% Triton X-100 in PBS for 5-10 minutes. After blocking with 1-5% BSA or normal serum in PBS for 30-60 minutes, cells are incubated with the primary RPS8 antibody diluted in blocking buffer overnight at 4°C or for 1-2 hours at room temperature.

Following thorough washing with PBS, cells are incubated with fluorophore-conjugated secondary antibody (appropriate for the host species of the primary antibody, typically anti-rabbit for the antibodies described in the search results) for 1-2 hours at room temperature in the dark. Nuclear counterstaining with DAPI or Hoechst and mounting with an anti-fade mounting medium completes the preparation.

For optimal results, researchers should consider the following technical considerations: (1) include a negative control by omitting the primary antibody to assess background fluorescence; (2) include positive controls with known RPS8 expression; (3) optimize fixation conditions, as overfixation can mask epitopes; (4) compare different permeabilization methods if initial results are suboptimal; and (5) test different antibody dilutions to determine the optimal signal-to-noise ratio for the specific experimental system.

How do post-translational modifications affect RPS8 function and detection?

RPS8 undergoes several post-translational modifications (PTMs) that can significantly impact both its biological function and detection in experimental systems. Understanding these modifications is crucial for comprehensive analysis of RPS8 in research contexts. According to UniProt data, RPS8 can undergo multiple types of PTMs, including N-terminal myristoylation (at G2), phosphorylation (at S4), acetylation (at K23 and K24), sumoylation (at K26), and ubiquitination .

These modifications may regulate RPS8's function, localization, stability, or interactions with other molecules. For instance, phosphorylation often serves as a regulatory switch affecting protein activity or interactions, while ubiquitination typically targets proteins for degradation. Acetylation can influence protein stability and function, particularly for nuclear proteins, and sumoylation often modulates protein-protein interactions or subcellular localization.

From an experimental perspective, these modifications present important considerations for antibody-based detection methods. Antibodies may have differential reactivity with modified versus unmodified forms of RPS8, potentially leading to incomplete detection or misinterpretation of results. For example, if an antibody's epitope contains or is adjacent to a modification site, the presence of that modification might enhance or inhibit antibody binding.

Researchers investigating RPS8 should consider several approaches to address PTM-related challenges: (1) utilize antibodies specific to particular modified forms if studying a specific PTM; (2) employ phosphatase or deacetylase treatments before immunodetection if total RPS8 levels are of interest; (3) combine immunoprecipitation with mass spectrometry to comprehensively characterize RPS8 modifications in a specific biological context; and (4) compare results obtained with antibodies recognizing different epitopes of RPS8 to ensure comprehensive detection.

What strategies can optimize antigen retrieval for RPS8 immunohistochemistry?

Effective antigen retrieval is critical for RPS8 immunohistochemistry, particularly when working with formalin-fixed, paraffin-embedded (FFPE) tissues where epitope masking due to fixation can significantly impair antibody binding. Based on published protocols, heat-induced epitope retrieval (HIER) using sodium citrate buffer has proven effective for RPS8 detection .

For tissues with dense extracellular matrix or those fixed for extended periods, more rigorous antigen retrieval methods may be necessary. Options include: (1) extending the heating time in sodium citrate buffer; (2) testing alternative retrieval buffers such as EDTA (pH 8-9) or Tris-EDTA, which may better expose certain epitopes; (3) employing pressure cooking or microwave heating methods, which can enhance retrieval efficiency; or (4) exploring enzymatic retrieval methods using proteases like proteinase K or trypsin as an alternative to heat-based methods.

When optimizing antigen retrieval for RPS8 detection, researchers should systematically compare different methods using positive control tissues known to express RPS8. Additionally, implementing a tiered approach is advisable—starting with standard conditions and progressively increasing retrieval intensity while monitoring both signal strength and tissue morphology preservation.

It's worth noting that excessive antigen retrieval can lead to tissue damage and increased background staining, while insufficient retrieval results in weak or absent specific staining. Therefore, careful titration of retrieval conditions is essential for optimal results. For quantitative studies, standardizing antigen retrieval conditions across all samples is crucial to ensure comparable results.

How can I validate the specificity of RPS8 antibody for my experimental system?

Antibody validation is a critical step in ensuring experimental rigor and reproducibility when working with RPS8. Several complementary approaches can be employed to thoroughly validate antibody specificity in your particular experimental system. First, Western blot analysis should reveal a single band at the expected molecular weight of 25-28 kDa in positive control samples such as HeLa cells, SGC-7901 cells, PC-3 cells, or A375 cells, which have been confirmed to express RPS8 .

RNA interference (RNAi) or CRISPR-Cas9 gene editing provides a powerful validation approach by comparing antibody signal between wild-type cells and those with reduced or eliminated RPS8 expression. A specific antibody should show significantly reduced signal in RPS8-depleted samples. Similarly, transient overexpression of tagged RPS8 should result in increased signal intensity at the expected molecular weight, potentially with a slight shift due to the tag.

Immunoprecipitation followed by mass spectrometry analysis can confirm that the antibody is capturing RPS8 rather than cross-reacting with other proteins. This approach is particularly valuable for confirming specificity in new experimental systems or when questioning existing antibody performance.

For immunohistochemistry or immunofluorescence applications, competing the antibody with the immunizing peptide (if available) should abolish specific staining while leaving any non-specific background unchanged. Additionally, comparing staining patterns produced by two independent antibodies targeting different epitopes of RPS8 can provide further validation—concordant staining patterns suggest specificity for the intended target.

Finally, knockout validation using tissues or cells from RPS8 knockout models (where viable) provides the gold standard for antibody validation, though the essential nature of ribosomal proteins may make complete knockouts challenging to obtain.

What are common troubleshooting issues with RPS8 antibody and their solutions?

Researchers working with RPS8 antibodies may encounter several common technical challenges that can be systematically addressed. One frequent issue is weak or absent signal in Western blot applications. This can result from insufficient protein loading, degraded protein samples, inefficient transfer, or suboptimal antibody dilution. Solutions include increasing protein concentration, adding fresh protease inhibitors during sample preparation, optimizing transfer conditions for low molecular weight proteins, and titrating the antibody concentration within the recommended range of 1:500-1:2000 .

High background is another common problem, particularly in immunohistochemistry and immunofluorescence applications. This may stem from inadequate blocking, excessive antibody concentration, or non-specific binding. Researchers should try increasing the blocking time or concentration (using 5% BSA as demonstrated in published protocols), further diluting the primary antibody within the recommended range of 1:20-1:200 for immunofluorescence , and adding 0.1-0.3% Triton X-100 to the antibody diluent to reduce non-specific interactions.

Multiple bands in Western blot can indicate potential cross-reactivity, protein degradation, or detection of differently modified forms of RPS8. To address this, researchers can increase the stringency of washing steps, ensure complete denaturation of proteins during sample preparation, and consider using freshly prepared samples with additional protease inhibitors.

For immunohistochemistry, inconsistent staining across different regions of a tissue section often results from incomplete deparaffinization, inadequate fixation, or uneven antigen retrieval. Solutions include extending the deparaffinization time, ensuring adequate fixation during sample preparation, and using a temperature-controlled system for antigen retrieval to ensure uniform heating.

False negative results may occur when the epitope is masked by protein-protein interactions or post-translational modifications. Researchers can try alternative antibodies targeting different epitopes of RPS8, adjust sample preparation methods to disrupt protein complexes more effectively, or employ specialized techniques to expose masked epitopes.

How can I design experiments to study RPS8 interactions with small nucleolar RNAs?

The unique genomic organization of RPS8, with small nucleolar RNA genes (snoRNAs) U38A, U38B, U39, and U40 located within its introns , presents intriguing opportunities for studying the functional relationship between this ribosomal protein and these regulatory RNAs. Designing experiments to investigate these interactions requires a multi-faceted approach combining molecular, cellular, and biochemical techniques.

RNA immunoprecipitation (RIP) represents a powerful starting approach. Using validated RPS8 antibodies, researchers can immunoprecipitate RPS8 protein complexes and then analyze the associated RNAs by RT-qPCR using primers specific for U38A, U38B, U39, and U40. This can establish whether direct physical interactions exist between RPS8 protein and these snoRNAs. Cross-linking before immunoprecipitation (CLIP) can enhance detection of transient or weak interactions.

Genetic manipulation experiments offer complementary insights. CRISPR-Cas9 could be employed to create specific deletions or mutations in the snoRNA sequences within the RPS8 gene, followed by analysis of effects on RPS8 expression, processing, and function. Similarly, overexpression of individual snoRNAs from exogenous constructs could reveal whether they regulate RPS8 expression or function.

Subcellular localization studies using fluorescent in situ hybridization (FISH) for the snoRNAs combined with immunofluorescence for RPS8 protein can determine whether these molecules co-localize within cellular compartments, suggesting functional association. Time-course experiments during cellular processes like stress response or differentiation might reveal coordinated regulation of RPS8 and its intronic snoRNAs.

For functional studies, knockdown of individual snoRNAs using antisense oligonucleotides followed by analysis of ribosome biogenesis, global translation, and specific mRNA translation efficiency can elucidate their roles in ribosome function. Mass spectrometry analysis of ribosome composition after snoRNA manipulation might reveal whether these RNAs influence RPS8 incorporation into the ribosomal complex.

Lastly, luciferase reporter assays using constructs containing the RPS8 introns with wild-type or mutated snoRNA sequences can determine whether these elements influence gene expression at the transcriptional or post-transcriptional level.

How is RPS8 implicated in alcohol-associated hepatocellular carcinoma?

Research has identified RPS8 as a potential specific biomarker for alcohol-associated hepatocellular carcinoma (HCC), distinguishing it from non-alcohol-associated HCC. Gene expression analysis has demonstrated that RPS8 is significantly upregulated in alcohol-associated HCC tissues compared to adjacent non-tumor tissues, while showing no significant differential expression in non-alcohol-associated HCC . This specificity suggests a unique relationship between alcohol-induced carcinogenesis and RPS8 expression.

Gene Set Enrichment Analysis (GSEA) has revealed that samples with high RPS8 expression in alcohol-associated HCC show enrichment in ten key pathways, including RNA polymerase and ribosome pathways . This suggests that RPS8 upregulation may contribute to altered translational regulation in alcohol-associated HCC, potentially promoting tumor progression through dysregulated protein synthesis.

Immunohistochemical evaluation of RPS8 protein levels in tissue samples provides a practical method for assessing its potential as a diagnostic biomarker. A scoring system based on the percentage of positive cells (0: 0-1%, 1: 1-33%, 2: 34-66%, and 3: 67-100%) has been employed to quantify RPS8 expression, with upregulation defined as higher percentage scores in tumor tissues compared to corresponding adjacent tissues .

For researchers investigating RPS8 in alcohol-associated HCC, several experimental approaches are recommended: (1) comparative expression analysis in larger cohorts of alcohol-associated versus non-alcohol-associated HCC; (2) correlation of RPS8 expression with clinical parameters such as tumor stage, grade, and patient survival; (3) mechanistic studies to determine whether RPS8 upregulation is a driver or consequence of alcohol-associated hepatocarcinogenesis; and (4) evaluation of RPS8 as a potential therapeutic target by assessing the effects of its knockdown on cancer cell proliferation, migration, and survival.

What is the significance of RPS8 in colorectal cancer research?

Increased expression of RPS8 has been observed in colorectal tumors and colon polyps compared to matched normal colonic mucosa , suggesting potential involvement in colorectal cancer (CRC) development or progression. This differential expression pattern positions RPS8 as a molecule of interest for CRC research, potentially serving as a diagnostic biomarker or therapeutic target.

For researchers investigating RPS8 in colorectal cancer, immunohistochemical analysis of tissue microarrays containing CRC samples at different stages alongside matched normal tissues can provide insights into the relationship between RPS8 expression and disease progression. Correlation of RPS8 expression levels with clinicopathological parameters such as tumor stage, grade, metastatic status, and patient survival can further elucidate its prognostic significance.

Mechanistic studies using CRC cell lines with RPS8 knockdown or overexpression can reveal its functional role in cancer-related processes such as proliferation, migration, invasion, and resistance to apoptosis. Xenograft models with modulated RPS8 expression can extend these findings to in vivo contexts, assessing effects on tumor growth, angiogenesis, and metastatic potential.

Investigation of RPS8's molecular interactions in CRC cells through techniques such as co-immunoprecipitation followed by mass spectrometry can identify cancer-specific binding partners that might mediate its oncogenic functions. Similarly, transcriptomic and proteomic analyses comparing control and RPS8-modulated CRC cells can reveal downstream pathways affected by altered RPS8 expression.

Given the fundamental role of ribosomes in protein synthesis, exploring whether RPS8 contributes to translational reprogramming in CRC represents an important research direction. Ribosome profiling and polysome fractionation experiments can determine whether RPS8 alterations affect global translation rates or the translation of specific mRNAs encoding oncoproteins or tumor suppressors.

What emerging techniques might enhance RPS8 research?

Emerging technologies offer exciting opportunities to advance RPS8 research beyond traditional antibody-based detection methods. Proximity labeling techniques such as BioID or APEX2 could be employed by fusing these enzymes to RPS8, allowing for the biotinylation of proteins in close proximity to RPS8 within living cells. This approach could reveal novel interaction partners and provide insights into the dynamic ribosomal and extra-ribosomal functions of RPS8.

CRISPR-Cas9 genome editing with knock-in of fluorescent tags enables live-cell imaging of endogenous RPS8, avoiding potential artifacts associated with overexpression systems. This approach allows for real-time visualization of RPS8 localization, dynamics, and incorporation into ribosomes under various physiological and pathological conditions.

Mass spectrometry-based approaches offer unprecedented insights into RPS8 biology. Targeted proteomics using selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) can provide absolute quantification of RPS8 in complex samples. Additionally, post-translational modification (PTM) mapping using specialized mass spectrometry techniques can comprehensively characterize modifications of RPS8 in different biological contexts, including the phosphorylation, acetylation, sumoylation, and ubiquitination sites identified in UniProt data .

Single-cell technologies could reveal heterogeneity in RPS8 expression and function across different cell populations. Single-cell RNA sequencing can identify cell types with differential RPS8 expression, while single-cell proteomics approaches, though still emerging, could eventually provide insights into cell-to-cell variation in RPS8 protein levels and modifications.

Cryo-electron microscopy (cryo-EM) with improved resolution could elucidate the structural role of RPS8 within the ribosome at near-atomic resolution, potentially revealing mechanistic insights into how alterations in RPS8 affect ribosome assembly or function. Similarly, integrative structural biology approaches combining multiple techniques could provide comprehensive understanding of RPS8's structural interactions.

Finally, ribosome profiling coupled with RPS8 manipulation could reveal how alterations in this protein affect the translation of specific mRNAs, potentially uncovering specialized functions of RPS8-containing ribosomes in translating distinct subsets of the transcriptome.

How might systems biology approaches advance understanding of RPS8 function?

Systems biology approaches offer powerful frameworks for comprehensively understanding RPS8's role within the complex networks of cellular processes. Network analysis integrating protein-protein interaction data, gene co-expression patterns, and functional genomics screening results can position RPS8 within broader cellular systems, revealing unexpected connections and functional relationships. For instance, the weight gene co-expression network analysis that identified RPS8 as a hub gene in alcohol-associated HCC represents an initial application of such approaches .

Multi-omics integration combining transcriptomics, proteomics, and potentially ribosome profiling data from experimental systems with modulated RPS8 levels can provide holistic views of how RPS8 perturbations propagate across multiple layers of cellular regulation. This integration might reveal compensatory mechanisms triggered by RPS8 alterations or identify unexpected cellular processes affected by RPS8 dysfunction.

Comparative genomics approaches analyzing RPS8 sequence conservation, expression patterns, and regulatory elements across species can provide evolutionary insights into its core functions versus species-specific adaptations. Similarly, analysis of natural genetic variation in human RPS8 through population genomics data might reveal associations with disease susceptibility or other phenotypic traits.

Drug-response profiling using cell lines with modulated RPS8 expression could identify synthetic lethal interactions, potentially revealing context-dependent vulnerabilities that could be therapeutically exploited in cancers with altered RPS8 expression. High-throughput screening of small molecule libraries for compounds that modulate RPS8 expression, localization, or interactions could yield valuable chemical probes for functional studies and potential therapeutic leads.

Finally, in silico approaches such as molecular dynamics simulations of RPS8 within the ribosomal context could provide insights into how specific mutations or modifications affect its structural stability and functional interactions, complementing experimental structural biology approaches.